Long-term data for BETAFERON

 

Long-term data from studies in early MS

Read more

Long-term data from studies in established RRMS

Read more

Long-term data on IFNB from observational MS patient cohorts

Read more
Alt tag

© 2022 Bayer AG

This website contains information on BETAFERON (interferon beta-1b) which is based on the Summary of Product Characteristics (SmPC) as approved by the European Commission. It is intended to provide information to an international audience outside of Austria, Canada, South Africa, Switzerland, the USA and UK

  • PP-BET-ALL-0236-1

Last updated on 08/11/2022